Chigusa Oda-Nakahashi
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
CD300a Immunoreceptor Blocking Attenuates Neuronal Apoptosis by Regulating Efferocytosis and Promotes Hindlimb Functional Recovery after Acute Spinal Cord Injury in Mice.
Journal: Journal of neurotrauma
Published: February 17, 2026
The Development of Monoclonal Antibodies Specific to the Soluble Form of CD155 in the Human Peripheral Blood.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: October 15, 2025
Circulating memory-phenotype CD4+ T cells rapidly accumulate in the ischemic gut to exacerbate tissue injury in an innate manner.
Journal: Cell reports
Published: August 11, 2025
A Humanized Monoclonal Antibody Against CD300A Ameliorates Acute Ischemic Stroke in Humanized Mice.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: January 13, 2025
Inhibitory immunoreceptors CD300a and CD300lf cooperate to regulate mast cell activation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 28, 2024
Immunoreceptor CD300a regulates ischemic tissue damage and adverse remodeling in the mouse heart and kidney.
Journal: The Journal of clinical investigation
Published: July 25, 2024
Development of Monoclonal Antibodies Specific to Either CD300AR111 or CD300AQ111 or Both.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: October 30, 2023
Protective effects of S100A8 on sepsis mortality: Links to sepsis risk in obesity and diabetes.
Journal: iScience
Published: June 03, 2022
Interferon-β promotes the survival and function of induced regulatory T cells.
Journal: Cytokine
Published: February 08, 2022
CD300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke.
Journal: Science immunology
Published: October 15, 2021
Last Updated: 09/26/2026